Growth Metrics

Eli Lilly (LLY) Minority Interest (2016 - 2025)

Eli Lilly filings provide 17 years of Minority Interest readings, the most recent being $57.5 million for Q3 2025.

  • On a quarterly basis, Minority Interest fell 28.75% to $57.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $57.5 million, a 28.75% decrease, with the full-year FY2024 number at $79.5 million, down 13.4% from a year prior.
  • Minority Interest hit $57.5 million in Q3 2025 for Eli Lilly, down from $76.2 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $219.1 million in Q2 2021 to a low of $57.5 million in Q3 2025.
  • Median Minority Interest over the past 5 years was $91.8 million (2023), compared with a mean of $113.8 million.
  • Biggest five-year swings in Minority Interest: soared 69.43% in 2021 and later plummeted 51.4% in 2022.
  • Eli Lilly's Minority Interest stood at $175.6 million in 2021, then decreased by 28.47% to $125.6 million in 2022, then dropped by 26.91% to $91.8 million in 2023, then fell by 13.4% to $79.5 million in 2024, then decreased by 27.67% to $57.5 million in 2025.
  • The last three reported values for Minority Interest were $57.5 million (Q3 2025), $76.2 million (Q2 2025), and $82.0 million (Q1 2025) per Business Quant data.